Mammaglobin and CRxA-01 in pleural effusion cytology: Potential utility of distinguishing metastatic breast carcinomas from other cytokeratin 7-positive/cytokeratin 20-negative carcinomas

Cancer

Volumn 102, Issue 6, 2004, Pages 368-372

  Ciampa, Armando ^a   Fanger, Gary ^b   Khan, Ashraf ^a   Rock, Kenneth L ^a   Xu, Bo ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

CK7 CK20; CRxA 01; Cytology; Malignant pleural effusion; Mammaglobin

Indexed keywords

ANTIBODY; COMPLEMENTARY DNA; CYTOKERATIN 1; CYTOKERATIN 20; CYTOKERATIN 7; MAMMAGLOBIN;

ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; CYTOLOGY; DNA LIBRARY; ENDOMETRIUM CARCINOMA; FEMALE; GASTROINTESTINAL CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOGENESIS; OVARY CARCINOMA; PLEURA EFFUSION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UROGENITAL TRACT CANCER; UTERUS CARCINOMA;

ANTIBODIES, NEOPLASM; BREAST NEOPLASMS; CARCINOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PLEURAL EFFUSION; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; UTEROGLOBIN;

EID: 10244259149     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20627     Document Type: Article

References (19)

1. Chu P, Wu E, Weiss ML. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol. 2000;13:962-972.
2. Moll R, Lowe A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol. 1992;140:427-447.
3. Chhieng CD, Cangiarella FJ, Zakowski FM, Goswami S, Cohen JM, Yee HT. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens. Cancer (Cancer Cytopathol). 2001;93:330-336.
4. van Niekerk CC, Jap PH, Ramaekers FC, van de Malengraft F, Poels LG. Immunohistochemical demonstration of keratin 7 in routinely fixed paraffin-embedded human tissues. J Pathol. 1991;165:145-152.
5. Wang NP, Zee S, Zarbo RJ, Bacchi CE, Gown AM. Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem. 1995;3:99-107.
6. Kaufmann O, Deidesheimer T, Muehlenberg M, Deick P, Dietel M. Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites. Histopathology. 1996;29:233-240.
7. Watson MA, Fleming TP. Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res. 1996;56:860-865.
8. Watson MA, Darrow C, Zimonjic DB, Popescu NC, Fleming TP. Structure and transcriptional regulation of the human mammaglobin gene, a breast cancer associated member of the uteroglobin family localized to chromosome 11q3. Oncogene. 1998;16:817-824.
9. Watson MA, Dintzis S, Darrow CM, et al. Mammaglobin expression in primary, metastatic, and occult breast cancer. Cancer Res. 1999;59:3028-3031.
10. Leygue E, Snell L, Dotwzlaw H, et al. Mammaglobin, a potential marker of breast cancer metastasis. J Pathol. 1999;189:28-33.
11. Aihara T, Fujiwara Y, Ooka M, Sakita I, Tamaki Y, Monden M. Mammaglobin B as a novel marker for detection of breast cancer micrometastases in axillary nodes by reverse transcription-polymerase chain reaction. Breast Cancer Res Treat. 1999;58:137-140.
12. Zach O, Kasparu H, Krieger O, Hehenwarter W, Girschikofsky M, Lutz D. Detection of circulating mammary carcinoma cells in peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA. J Clin Oncol. 1999;17:2015-2019.
13. Lin YC, Wu Chou YH, Liao IC, Cheng AJ. The expression of mammaglobin mRNA in peripheral blood of metastatic breast cancer patients as an adjunct to serum tumor markers. Cancer Lett. 2003;191:93-99.
14. Silva JM, Dominguez G, Silva J, et al. Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics. Clin Cancer Res. 2001;7:2821-2825.
15. Nunez-Villar MJ, Martinez-Arribas F, Pollan M, et al. Elevated mammaglobin (h-MAM) expression in breast cancer is associated with clinical and biological features defining a less aggressive tumor phenotype. Breast Cancer Res. 2003;5:R65-R70.
16. Lin YC, Chen SC, Hsueh S, et al. Lack of correlation between expression of human mammaglobin mRNA in peripheral blood and known prognostic factors for breast cancer patients. Cancer Sci. 2003;94:99-102.
17. Stachurski D, Fanger G, Xu B, et al. CRxA-01 and mammaglobin expression in breast cancer: potential role in differentiating breast cancer from other CK7+/CK20- tumors (abstract). Mod Pathol. 2003;16:48A.
18. Sica GL, Choi IH, Zhu G, et al. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity. 2003;18:849-861.
19. Fujita J, Ohtsuki Y, Bandoh S, et al. Expression of thyroid transcription factor-1 in 16 human lung cancer cell lines. Lung Cancer. 2003;39:31-36.